PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1972 February; 65(2): 128–129.
PMCID: PMC1644142

Gestronol hexanoate (SH582) and benign prostatic hypertrophy.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (338K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Aubrey DA, Khosla T. The effect of 17-alpha-hydroxy-19-norprogesterone caproate (SH582) on benign prostatic hypertrophy. Br J Surg. 1971 Sep;58(9):648–652. [PubMed]
  • LOGE JP. INSECT-STING ALLERGY: QUESTIONNAIRE STUDY OF 2,606 CASES. JAMA. 1965 Jul 12;193:115–120. [PubMed]
  • Hahn JD, Neumann F, Berswordt-Wallrabe R. Tierexperimentelle Untersuchungen mit 19-nor-17 alpha-hydroxyprogesteron-capronat (Gestenoroncapronat) im Hinblick auf eine mögliche therapeutische Anwendung beim Prostataadenom. Urologe. 1968 Jul-Aug;7(4):208–214. [PubMed]
  • Nuri M, Hochberg K. Behandlung der Prostata-Hypertrophie mit Depostat. Munch Med Wochenschr. 1970 May 29;112(22):1057–1060. [PubMed]
  • Schoonees R, de Klerk JN, Murphy GP. The effect of depostat (SH 582) on the baboon prostate. J Surg Oncol. 1969;1(4):317–324. [PubMed]
  • Vahlensieck W, Gödde S. Behandlung der Prostatahypertrophie mit Gestagenen. Munch Med Wochenschr. 1968 Jun 28;110(26):1573–1577. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press